Dramatic remissions seen in immunotherapy trial of blood cancer patients

fredhutch.org October 1, 2016

Many patients with advanced blood cancers who are receiving experimental, "living" immunotherapy as part of a clinical trial are experiencing sustained remissions, according to preliminary results of the ongoing study at Fred Hutchinson Cancer Research Center.

cancer immunotherapy research study trial

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Haloperidol vs. Placebo in ICU Patients with Delirium

Haloperidol vs. Placebo in ICU Patients with Delirium

10 Reasons for Pharmacy Professionals Presence in the ICU

10 Reasons for Pharmacy Professionals Presence in the ICU

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care Secrets

A Perspective on Post-Cardiac Arrest Syndrome

Textbook of Critical Care

Clinical, Biological and Molecular Aspects of COVID-19

Essentials of Mechanical Ventilation

A Thousand Naked Strangers: A Paramedic’s Wild Ride to the Edge and Back

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between